Skip to main content

Cafepharma Today

July 15 2025 - China biotechs ‘reshaping’ US biopharma as outlicensing deals rise 11%: Jefferies report

China biotechs ‘reshaping’ US biopharma as outlicensing deals rise 11%: Jefferies report
Pharma/biotech general discussion board
As GSK eyes Blenrep's US return, FDA flags eye safety concerns ahead of advisory committee meeting
GSK board
Quest to offer Fujirebio’s FDA-cleared Alzheimer’s blood test
Diagnostics boards
Kenvue CEO Mongon leaves the consumer health company as it continues its strategic review
Kenvue board
*please scroll down for all the latest news*

Check open job listings in your area
Click here to the top four headlines in your inbox Mon-Fri (free)

learn about pharmaceutical fraud
learn about the False Claims Act

Current News

Many US employers plan to pare health benefits as weight-loss spending soars
MSN/Reuters
employers, insurance, weight loss, coverage
Repare finds suitor for paused PKMYT1 inhibitor in current partner Debiopharm
Fierce Biotech
Repare Therapeutics, lunresertib, Debiopharm
CMS reaches outcome-based deal with drugmakers to treat sickle cell disease
Beckers Hospital Review
sickle cell disease, gene therapy, CMS, Medicaid
Federal judge rules Novartis cannot block generic Entresto launch by MSN Pharmaceuticals until late 2026
Gene Online
legal, Novartis, MSN Pharmaceuticals, patents, generics, Entresto
Weight-loss drug use in kids surged after doctors' recommendation
Axios
weight loss, pediatric, AAP, GLP-1 agonist
GSK telegraphs 'very limited number' of job cuts amid R&D investment spree
Fierce Biotech
GSK, layoffs, R&D
DOGE makes its way into biotech IPO filings
Axios
DOGE, biotech, IPOs, uncertainty
AstraZeneca sifts for efficacy crumbs in amyloidosis trial
Pharmaphorum
AstraZeneca, light chain amyloidosis, anselamimab
FDA fast-tracks Sanofi's gene therapy for eye disease GA
Pharmaphorum
Sanofi, gene therapy, FDA, geographic atrophy
China biotechs ‘reshaping’ US biopharma as outlicensing deals rise 11%: Jefferies report
Fierce Biotech
China, biotech, Bristol Myers Squibb, Roche, Merck, Pfizer, Gilead Sciences
Otsuka to acquire Cantargia’s CAN10 for autoimmune diseases
Yahoo Finance
Otsuka, Cantargia, CAN10, autoimmune diseases
As GSK eyes Blenrep's US return, FDA flags eye safety concerns ahead of advisory committee meeting
Fierce Pharma
GSK, Blenrep, FDA, antibody-drug conjugates
Quest to offer Fujirebio’s FDA-cleared Alzheimer’s blood test
Medtech Dive
Medtech, diagnostics, Quest Diagnostics, Fujirebio Diagnostics, FDA, Alzheimer's disease
HHS begins formally laying off employees
BioSpace
HHS, layoffs, Supreme Court, Donald Trump
Sun Pharma launches key alopecia drug in US, experts estimate $200–300 million market potential
Financial Express
Sun Pharma, Leqselvi, alopecia areata
Sources: FDA won’t pay bonuses to RIFed, similar employees
RAPS.org
FDA, layoffs, Donald Trump
Sino Biopharm buys Merck's PD-1xVEGF bispecific partner LaNova for up to $951M
Fierce Biotech
M&A, Sino Biopharmaceuticals, LaNova Medicines
Kenvue CEO Mongon leaves the consumer health company as it continues its strategic review
AP News
Kenvue, consumer health, JNJ, Thibaut Mongon
Biotech IPO momentum gained steam last year, but market ‘turmoil’ has slowed the train again
Pharma Voice
biotech, IPOs
Hengrui to file obesity shot in China after phase 3 win
Pharmaphorum
Hengrui Pharma, Kailera Therapuetics, obesity, China



Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles